Anti-SRP autoantibodies occur almost exclusively in patients with polymyositis, a syndrome characterized by chronic muscle inflammation of unknown cause [12-14], and they seem to define a distinct phenotypic, genetic and epidemiologic subgroup of myositis patients [15,16]. The gene discussed is UCN2; the disease is myositis disease.